• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Research Brief on 2-(3-hydroxypropyl)cyclohexan-1-one (CAS: 62456-11-5) in Chemical Biology and Pharmaceutical Applications

The compound 2-(3-hydroxypropyl)cyclohexan-1-one (CAS: 62456-11-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This research brief synthesizes the latest findings on this compound, focusing on its synthesis, biological activities, and potential therapeutic uses. The growing interest in this molecule is driven by its unique structural features, which make it a promising candidate for various medicinal chemistry applications.

Recent studies have explored the synthetic pathways for 2-(3-hydroxypropyl)cyclohexan-1-one, highlighting its efficient production through catalytic hydrogenation and other advanced chemical methods. Researchers have optimized reaction conditions to achieve high yields and purity, which are critical for its subsequent use in pharmaceutical formulations. The compound's structural flexibility allows for further derivatization, enabling the development of novel analogs with enhanced biological activities.

In terms of biological applications, 2-(3-hydroxypropyl)cyclohexan-1-one has demonstrated notable pharmacological properties, including anti-inflammatory and antimicrobial effects. Preliminary in vitro studies indicate its potential as a lead compound for treating inflammatory diseases, with mechanisms involving the modulation of key signaling pathways such as NF-κB. Additionally, its antimicrobial activity against a range of pathogens suggests its utility in addressing antibiotic resistance, a pressing global health challenge.

Further investigations into the compound's pharmacokinetics and toxicity profiles are underway to assess its suitability for clinical development. Early results suggest favorable bioavailability and low toxicity, positioning it as a viable candidate for further preclinical testing. Researchers are also exploring its potential in combination therapies, where it may enhance the efficacy of existing drugs or reduce adverse effects.

In conclusion, 2-(3-hydroxypropyl)cyclohexan-1-one (CAS: 62456-11-5) represents a promising molecule in the chemical biology and pharmaceutical landscape. Its multifaceted applications, from drug synthesis to therapeutic use, underscore its importance in ongoing research efforts. Future studies will likely focus on expanding its therapeutic scope and optimizing its properties for clinical translation, making it a compound of significant interest for researchers and industry professionals alike.

• 220199-90-6(Cyclohexanone,2-(hydroxymethyl)-, (2S)-)
• 38580-68-6(4-(Hydroxymethyl)cyclohexanone)
• 32916-58-8(3-(Hydroxymethyl)cyclohexanone)
• 5331-08-8(2-(Hydroxymethyl)cyclohexanone)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)